Skip to main navigation Skip to search Skip to main content

Ambler class C-type β-lactamases and porin alterations in Enterobacter cloacae complex and Klebsiella aerogenes in the Netherlands, 2012–2023

  • Elke Van Gorp
  • , Simon Lansu
  • , Cornelia C. H. Wielders
  • , Angela De Haan
  • , Gert-Jan Godeke
  • , Sandra Witteveen
  • , Jeroen Bos
  • , Fabian Landman
  • , Maureen Ouw
  • , Herman F. Wunderink
  • , Maurits P. A. Van Meer
  • , Wil Van Der Zwet
  • , Daan W. Notermans
  • , Antoni P. A. Hendrickx*
  • , A. L. E. Van Arkel
  • , M. A. Leversteijn-van Hall
  • , W. Van Den Bijllaardt
  • , R. Van Mansfeld
  • , K. Van Dijk
  • , B. Zwart
  • B. M. W. Diederen, H. Berkhout, A. Ott, K. Waar, W. Ang, J. Da Silva, A. L. M. Vlek, J. J. J. M. Stohr, L. G. M. Bode, A. Jansz, S. Paltansing, A. J. Van Griethuysen, J. R. Lo Ten Foe, M. J. C. A. Van Trijp, M. Wong, A. E. Muller, M. P. M. Van Der Linden, M. Van Rijn, S. B. Debast, E. Kolwijck, N. Al Naiemi, T. Schulin, S. Dinant, S. P. Van Mens, D. C. Melles, J. W. T. Cohen Stuart, P. Gruteke, A. P. Van Dam, I. Maat, B. Maraha, Et al.
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We investigated the genomic epidemiology of Ambler class C (AmpC-type) β-lactamases in Enterobacter cloacae complex and Klebsiella aerogenes in the national carbapenemase-producing Enterobacterales (CPE) surveillance of the Netherlands between 2012 and 2023. A total of 399 E. cloacae complex and K. aerogenes isolates from 399 patients were analyzed using whole-genome sequencing to assess genetic relatedness, resistance genes, porin, and AmpC-regulatory gene profiles, plasmid replicons, and the genomic location of AmpC-genes, respectively. Of the 399 patients, 217 were male (54%), and the median age was 67 years. Carbapenemase production was assessed using the carbapenem inactivation method (CIM) and CarbaNP-test. A considerable proportion of E. cloacae complex (32%) and K. aerogenes (52%) isolates were CIM-positive in the absence of detectable carbapenemase genes (IMP, KPC, NDM, OXA-48-like, VIM) by the CarbaPCR, a phenotype termed CIM + Carba-. These isolates were mostly (81.9%) susceptible (EUCAST ≤ 2mg/L) to meropenem. The majority of CIM + Carba + isolates with major carbapenemase genes were gained from pre-emptive screening, while CIM + Carba- isolates were mainly taken for diagnostic purposes. Genomic analysis identified 18 genogroups, with E. kobei, E. roggenkampii, E. ludwigii, and K. aerogenes showing the CIM + Carba- phenotype, were mostly lacking porins and AmpC regulators, and correlated with chromosome-encoded AmpC-type β-lactamases like bla ACT-28, bla ACT-52,bla MIR-3, bla MIR-11 or ampC of which the majority (63%) yielded a positive CarbaNP-test. These CIM + Carba- isolates carried only few plasmids, and there was limited evidence of nosocomial spread. CIM + Carba- E. kobei carrying bla ACT-28 overproduced ACT-28 protein in the CIM. Overall, the Enterobacter and K. aerogenes population in the Netherlands is genetically diverse, with most isolates carrying species-specific AmpC-type β-lactamases. Isolates with low MIC for meropenem that lack porins and major carbapenemases represent a low-risk for public health.

Original languageEnglish
Article number192
Number of pages17
JournalBMC Microbiology
Volume26
Issue number1
DOIs
Publication statusPublished - 30 Jan 2026

Keywords

  • AmpC
  • Enterobacter
  • <italic>K. aerogenes</italic>
  • Surveillance
  • Carbapenemase
  • ACT
  • MIR
  • Carbapenem inactivation method
  • Whole genome sequencing
  • Resistance
  • Carbapenemase activity
  • RESISTANCE
  • AMPC
  • EXPRESSION
  • ERTAPENEM

Fingerprint

Dive into the research topics of 'Ambler class C-type β-lactamases and porin alterations in Enterobacter cloacae complex and Klebsiella aerogenes in the Netherlands, 2012–2023'. Together they form a unique fingerprint.

Cite this